Tapering Sertraline and Starting Bupropion
For a patient on 25 mg sertraline wishing to switch to bupropion, you can safely stop sertraline abruptly at this very low dose and start bupropion immediately, as the risk of withdrawal symptoms is minimal at 25 mg.
Rationale for Direct Switch
At 25 mg sertraline (which is 25% of the minimum therapeutic dose of 100 mg), the risk of discontinuation syndrome is extremely low. The FDA label for sertraline notes that discontinuation symptoms are primarily associated with paroxetine, fluvoxamine, and sertraline at therapeutic doses 1. Research on tapering indicates that patients at low risk of withdrawal can use 25-50% dose reductions over 2-6 weeks, but this applies to therapeutic doses 2. Your patient is already at a sub-therapeutic dose.
Specific Switching Protocol
Day 1:
- Stop sertraline 25 mg (no taper needed)
- Start bupropion SR 150 mg once daily in the morning
Days 1-7:
- Continue bupropion SR 150 mg once daily
- Monitor for activation symptoms (anxiety, insomnia, agitation)
Day 8 onward (if tolerated):
- Increase to bupropion SR 150 mg twice daily (maximum 300 mg/day)
- Take second dose before 3 PM to minimize insomnia risk 3, 4
Critical Monitoring Points
Watch for these specific symptoms in the first 2 weeks:
- Withdrawal symptoms (unlikely at 25 mg sertraline): headache, dizziness, nausea, irritability, electric shock-like sensations 1
- Bupropion activation: increased anxiety, insomnia, agitation, restlessness 3, 5
- Worsening depression or suicidality: requires immediate clinical contact 6, 1
The American College of Physicians guideline recommends assessing patient status within 1-2 weeks of initiating antidepressant therapy 6, which is particularly important during this switch.
Contraindications and Precautions for Bupropion
Do not use bupropion if the patient has:
- History of seizures or eating disorders (lowers seizure threshold) 3, 5
- Brain metastases or stroke history 3
- Current use of MAOIs (requires 2-week washout) 1
- Closed-angle glaucoma 3
Use caution with:
- Concomitant medications metabolized by CYP2D6 (bupropion is an inhibitor) 5
- History of bipolar disorder (can precipitate mania) 6
Why Not Mirtazapine
Since you specifically want to avoid mirtazapine, this is appropriate as mirtazapine has distinct side effect profile including significant sedation, weight gain (49% of pediatric patients gained ≥7% body weight in trials), and increased appetite 4, 7. Bupropion, in contrast, is activating and associated with lower rates of sexual dysfunction and weight gain 6, 8.
Alternative: Conservative Cross-Taper (If Patient Prefers)
If the patient has anxiety about stopping sertraline abruptly despite the low dose:
Week 1: Sertraline 25 mg + Bupropion SR 150 mg daily
Week 2 onward: Stop sertraline, continue bupropion SR 150 mg daily, then increase to 150 mg twice daily as tolerated
However, this conservative approach is not necessary at 25 mg sertraline and adds unnecessary medication overlap.
Expected Timeline for Response
Assess therapeutic response at 6-8 weeks 6. If inadequate response, consider dose optimization or alternative strategies. Bupropion has been shown effective for depression at 300 mg daily 5, and can be particularly beneficial for patients with hypersomnia, fatigue, or increased appetite 9.